U

Umoja Biopharma

In vivo CAR T-cell cancer therapy

Director of Program Management

Program ManagementConfirmed live in the last 24 hours
Full-timeSeattle, WA, USA$207k - $309k

About the Job

Requirements

  • A bachelor's degree is required; an MBA or other advanced degree in immunology, biology, or genetics is highly preferred.
  • Director level requires a minimum of 10 years of experience, including at least 5 years in program management in a pharmaceutical or biotech setting.
  • Senior Director level requires a minimum of 12 years of experience, including at least 7 years in program management in a pharmaceutical or biotech setting, and at least 2 years of people-management experience.
  • Experience leading oncology, autoimmune disease, or gene and cell therapy programs.
  • Successful experience overseeing IND-stage and clinical programs; experience with INDs and ex-US equivalents is strongly desired.
  • Ability to present effectively and comfortably to leadership, peers, and executive teams.
  • Ability to build strong relationships and partnerships to positively influence successful outcomes.
  • Ability and judgment to make decisions, including difficult ones, and advance ideas in the company's best interest.
  • Ability to communicate effectively across all organizational levels and simplify complex ideas for varied audiences.
  • Advanced skills using Smartsheet, OnePager, or other project management tools.
  • Strong technology skills, including Outlook, PowerPoint, SharePoint, Excel, and Microsoft Teams.
  • Ability to work onsite at least three days per week in the Seattle office.
  • Ability to sit for prolonged periods.
  • Ability to travel as needed.

Responsibilities

  • Manage and lead cross-functional teams to advance programs into and through clinical trials.
  • Partner with project teams and functional leadership to create development strategies and options, define goals and milestones, track and report program progress, identify and escalate gaps and challenges, and execute asset development plans.
  • Drive effective, inclusive, and collaborative program and alliance teams, ensuring robust discussions and optimized operational plans to enable efficient drug development.
  • Support product and governance decisions using effective meeting practices, including agendas, meeting minutes, decision logs, and action logs, to support durable decisions, implementation, and follow-up.
  • Own program team operating rhythm and documentation, including integrated timelines, risk and issue registers, decision and action logs, and meeting records, ensuring accountability, transparency, and audit-ready records.
  • Ensure clear and consistent program communications across the organization, including systematic reporting such as monthly reports and milestone tracking.
  • Support Portfolio & Program team functional goals to develop consistent program and project management practices, build infrastructure, and improve ways of working.
  • Provide alliance management support for assigned partnered programs, maintain strong alliance relationships, and advance partnership excellence practices within Umoja.
  • Partner with Finance, Business Operations, and other functional stakeholders on corporate program planning, including cross-functional resource planning and financial assessments.
  • Support initiatives and special projects as needed.
  • Coach, mentor, and direct the activities of other program/project managers and/or contractors as needed.

Desired Qualifications

  • PMP or equivalent program/project management certification.
  • Experience as a program manager in a growing or start-up biotech environment.
  • Demonstrated leadership capabilities in a scientific, multidisciplinary setting.
  • Demonstrated ability to drive initiatives in a fast-paced, nimble environment.
  • Experience with INDs and ex-US equivalents.

About the Company

Umoja Biopharma

In vivo CAR T-cell cancer therapy

Umoja Biopharma develops immunotherapies that reprogram patients’ T cells inside the body (in vivo) to attack cancer. Its main product approach is a CAR T-cell gene therapy platform designed to be produced in-house and sold as off-the-shelf regimens, enabling scalable treatment for both solid tumors and blood cancers that have not responded to other therapies. The treatment works by modifying the patient’s immune system directly in the body to create CAR T cells that can target and kill cancer cells, aiming for lasting remissions. Unlike many therapies that extract cells from a patient, modify them outside the body, and then reinsert them, Umoja Biopharma focuses on in-body cell reprogramming and in-house manufacturing to streamline delivery. The company differentiates itself through its in vivo, off-the-shelf CAR T approach and its goal of broad applicability across cancer stages, seeking to provide accessible, scalable cancer treatments across solid and hematologic cancers.

Company size
201-500
Company stage
Series C
Total funding
$363M
Headquarters
Seattle, WA
Founded
2019

Recently Posted Jobs

Explore more opportunities at Umoja Biopharma

See more jobs